Dr. rer. nat. Kamal Al-Shami

Role in LiSyM-Cancer

• SMART-NAFLD
• Schulze Lab

Expertise

• Biochemistry
• Lipidomics
• Molecular Biology
• Liver metabolism
• Metabolism
• Wet lab
• Cell cultivation
• Tumor biology
• Animal models

Professional Experience
Postdoctoral Researcher with PhD-training in molecular biologist and clinical pharmacist with eight years of experience in cancer metabolism, molecular oncology, advanced biomolecular and preclinical techniques.

Degrees

• PhD (Dr. rer. nat.)
  Heidelberg University
  Defining oncogene-specific metabolic alterations in a mouse model of hepatocellular carcinoma for therapeutic targeting

  • Fellowship in Responsible Conduct of Research (RCR), UCSD and JUST, Jordan & USA

• Master of Science: Clinical Pharmacy
  Jordan University of Science and Technology
  Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

• Bachelor of Science: Pharmacy
  Jordan University of Science and Technology

Honors and Awards

• Scholar-in-training Award, American Association for Cancer Research (AACR) 2024, USA
• Graduate School Scholarship Program, German academic exchange service (DAAD), Germany
• In-Country/In-Region scholarship, German Academic Exchange Service (DAAD), Germany